Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

Abstract Background Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug inno...

Full description

Bibliographic Details
Main Authors: Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Antimicrobial innovation
Antibacterial innovation
DRIVE-AB
Pharmaceutical research and development
Online Access:http://link.springer.com/article/10.1186/s40545-018-0135-0

Internet

http://link.springer.com/article/10.1186/s40545-018-0135-0

Similar Items